William C. Sessa, PhD

Alfred Gilman Professor of Pharmacology and Professor of Medicine (Cardiology); Vice Chairman, Pharmacology; Director, Vascular Biology & Therapeutics Program

Departments & Organizations

Developmental Therapeutics

Developmental Therapeutics

Diabetes Research Center

NIH T32 Program

Office of Student Research

Pharmacology: Primary Faculty | Sessa Lab

Skin Diseases Research Center, Yale

Vascular Biology and Therapeutics Program

Yale Combined Program in the Biological and Biomedical Sciences (BBS): Molecular Cell Biology, Genetics and Development | Molecular Medicine, Pharmacology, and Physiology

Education & Training

PhD New York Medical College (1989)
Post-doctoral fellow Pharmacology, The University of Virginia Health Sciences Center
Post-doctoral fellow/Senior Scientist The William Harvey Research Institute

International Activity

  • International Scientific Board London, United Kingdom (2012 - 2017)

    Dr. Sessa is a member of the Scientific Advisory Board to the William Harvey Research Institute [WHRI] and the NIHR Biomedical Research Unit [BRU] in London.

  • YALE-UCL Collaborative London, United Kingdom (2011)

    Dr. Sessa is on the Joint Strategy Committee for the Yale-UCL Collaborative, an alliance which will provide opportunities for high-level scientific research, clinical and educational collaboration across the institutions involved: Yale University, Yale School of Medicine, Yale-New Haven Hospital...

  • Cardiovascular Research United Kingdom (2011)

    Yale-Cambridge Program in Cardiovascular Research that focuses on arteriosclerosis, angiogenisis, vascular injury, and transplantation.

Edit this profile